ArticleJTO clinical and research reports2023

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC.

Yuhei Kinehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.